Nivolumab in Recurrent and/or Metastatic SCCHN

Condition:   Recurrent and/or Metastatic Platinum-refractory SCCHN
Intervention:   Drug: Nivolumab Injection
Sponsors:   UNICANCER;   Bristol-Myers Squibb
Not yet recruiting - verified July 2017

http://ift.tt/2v03xq7